Cayaban, Euniza D.

HRN: 22-69-02  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/01/2023
CEFUROXIME 750MG (VIAL)
03/01/2023
03/08/2023
IV
1.5gm Then 750mg
Q8
Fracture, Surgical Management

 Indication:  ProphylaxisEmpiric    Type of Infection:  Bone & Joint    Compliance to guidelines: Non-compliant To Guidelines